Breaking news: $28M raised in series C funding Read News
We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.
CE marked and FDA cleared
Here’s a short introduction to what we do
Trusted in more than 25 countries
FDA cleared and CE marked for 2D and 3D mammography
The most independent peer reviewed publications in breast AI
Proven multivendor compatibility
Integrated with most workstations
Experience the benefit of our continuously evolving deep learning algorithm
Accuracy.
Workload Reduction.
Risk.
"The ScreenPoint team is a smart and innovative group. Transpara should have a beneficial impact on any breast imaging practice."
“I could see the potential benefits of using AI for my practice and for my patients and it was a real success. With each release, the Transpara algorithms are continually getting better and better. I use it all the time and won’t read another 3D mammogram without it!”
“Transpara may allow discriminating studies, which require more attention and selection of those, which may be handled with single reading for example. It may thus contribute significantly to both risk adapted screening and optimum assignment of resources."
"We are at the forefront of one of the first prospective studies with Transpara. As we will implement Transpara in a real-life screening setting in Ostergotland County, we aim to improve the quality of the breast cancer screening program while at the same time safely reduce the workload of breast radiologists."
Client undergoes mammogram
Transpara analyses mammogram scan
Radiologist reads with support from Transpara, increasing confidence in decision
Make more accurate and consistent decision
It follows a year of major achievements for the organisation with Transpara which is now installed in health care facilities
Read moreAidoc, the leading provider of AI for medical imaging, and ScreenPoint Medical, leader of deep learning AI for 2D and
Read moreThe Transpara deep learning artificial intelligence (AI) software, which helps radiologists identify breast cancers faster and earlier, has now been
Read moreAnother publication to add to the strong global evidence base supporting Transpara. This time in the Radiology journal, showing the
Read moreWe are very excited to have Dr Rachel Brem and Allyson White join our ScreenPoint Medical supervisory board. We are
Read moreHere’s our HR Manager, Marieke on why you should consider joining our dynamic team today to help make a difference
Read more
